Literature DB >> 20447710

Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings.

David Beran1, John S Yudkin.   

Abstract

Insulin's indispensible nature is recognised by its inclusion in the World Health Organization's Essential Medicines List. Despite this insulin is still not available on an uninterrupted basis in many parts of the developing world. The International Insulin Foundation has conducted in-country assessments and based on these findings, the barriers to access to insulin were more to do with problems linked distribution, tendering and government policies than purely accessibility and affordability issues. Lack of insulin leads to poor outcomes for people with diabetes, but access to medicines alone cannot improve levels of health in resource poor settings. Aspects such as strong political will and local champions, data, trained healthcare workers and diabetes associations are just as necessary. Strengthening health systems and developing sustainable and locally owned solutions are vital to improve health and health care for people with diabetes and other chronic conditions in resource poor settings. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20447710     DOI: 10.1016/j.diabres.2010.03.029

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  27 in total

Review 1.  The impact of health systems on diabetes care in low and lower middle income countries.

Authors:  David Beran
Journal:  Curr Diab Rep       Date:  2015-04       Impact factor: 4.810

2.  A Low-Cost Inkjet-Printed Glucose Test Strip System for Resource-Poor Settings.

Authors:  Kayla Gainey Wilson; Patrick Ovington; Delphine Dean
Journal:  J Diabetes Sci Technol       Date:  2015-06-12

Review 3.  Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.

Authors:  David Beran; Margaret Ewen; Kasia Lipska; Irl B Hirsch; John S Yudkin
Journal:  Curr Diab Rep       Date:  2018-06-16       Impact factor: 4.810

Review 4.  Clinical management of concurrent diabetes and tuberculosis and the implications for patient services.

Authors:  Anca Lelia Riza; Fiona Pearson; Cesar Ugarte-Gil; Bachti Alisjahbana; Steven van de Vijver; Nicolae M Panduru; Philip C Hill; Rovina Ruslami; David Moore; Rob Aarnoutse; Julia A Critchley; Reinout van Crevel
Journal:  Lancet Diabetes Endocrinol       Date:  2014-09       Impact factor: 32.069

5.  Non-communicable diseases in Mozambique: risk factors, burden, response and outcomes to date.

Authors:  Carla Silva-Matos; David Beran
Journal:  Global Health       Date:  2012-11-21       Impact factor: 4.185

Review 6.  Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review.

Authors:  Victoria Hall; Reimar W Thomsen; Ole Henriksen; Nicolai Lohse
Journal:  BMC Public Health       Date:  2011-07-14       Impact factor: 3.295

7.  "It is the medicines that keep us alive": lived experiences of diabetes medication use and continuity among adults in Southeastern Tanzania.

Authors:  Emmy Metta; Hinke Haisma; Flora Kessy; Eveline Geubbels; Inge Hutter; Ajay Bailey
Journal:  BMC Health Serv Res       Date:  2015-03-18       Impact factor: 2.655

8.  Comparative functional exercise capacity of patients with type 2-diabetes and healthy controls: a case control study.

Authors:  Taofeek Oluwole Awotidebe; Rufus Adesoji Adedoyin; Abraar Olalakan Yusuf; Chidozie Emmanuel Mbada; Rose Opiyo; Frasier Chidyaonga Maseko
Journal:  Pan Afr Med J       Date:  2014-11-07

9.  Medicines availability for non-communicable diseases: the case for standardized monitoring.

Authors:  Jane Robertson; Cécile Macé; Gilles Forte; Kees de Joncheere; David Beran
Journal:  Global Health       Date:  2015-05-07       Impact factor: 4.185

Review 10.  The co-management of tuberculosis and diabetes: challenges and opportunities in the developing world.

Authors:  Timothy Sullivan; Yanis Ben Amor
Journal:  PLoS Med       Date:  2012-07-24       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.